E-mail address: veronica.giusti@ior.it
Giusti Veronica, PhD
CV
Date of Birth
13/02/1990
Qualification
PhD
Current assignment
Biotechnologist
Title of qualification awarded
- 2015: PhD in Oncology, Ematology and Patology at the University of Bologna. Dissertation title: Preclinical development of novel therapies in models resistant to HER2 targeted therapies in HER2-positive breast cancer
- 2015: MSc in Pharmaceuticals, Veterinary and Medical Biotechnologies at the University of Bologna. Dissertation title: HER2-loss and sensibility to targeted therapies in breast cancer. Final mark: 110/110 cum laude
- 2012: BSc in Biotechnologies at the University of Bologna. Dissertation title: Role of oestrogen receptors in breast cancer. Final mark: 110/110 cum laude
- 2009: Scientific Diploma at the Lyceum "L. Galvani" of Bologna, final mark: 100/100.
Positions held
- 2020: Biotechnologist, Laboratory of Experimental Oncology, Rizzoli Orthpaedic Institute
- 2019-20: Post doctoral fellowship: Laboratory of Immunology e Metastases Biology, UNIBO
- 2019: Graduate attender: Laboratory of Immunology e Metastases Biology, UNIBO
- 2019: Temporary contract: Laboratory of Immunology e Metastases Biology, UNIBO
- 2018: PhD visiting student: Panum Institute, University of Copenhagen
- 2018: PhD Fellowship: Laboratory of Metastes Biology and Immunology, DIMES
- 2015: Graduate attender: Laboratorio di Biologia e Immunologia delle Metastasi
- 2014-15: Undergraduate Internship:Laboratory of Immunology e Metastases Biology, UNIBO
- 2012: Undergraduate Internship: Laboratory of Biochemistry, UNIBO.
Languages
- Inglese: fluente, livello Europass B2 (First Certificate)
- Tedesco: eccellente, livello Europass C1 (Deutsches Zertifikat).
Technologies
Word, Excel, PowerPoint, Access, Publisher, PhotoShop, TotalLab, FCSExpress, GaphPad Prism, CFX Manager Software, David Array, Enrichr, STRING, Panther, Benchling, Pubmed, Blast.
Scientific activities
Volume in preparazione: Lorena Landuzzi, Marianna L. Ianzano, Claudio Ceccarelli, Enrico Di Oto, Giordano Nicoletti, Veronica Giusti, Roberta Laranga, Tania Balboni, Carla De Giovanni, Massimiliano Dall'Ora, Sofia Asioli, Arianna Palladini, Donatella Santini, Maria Pia Foschini, Mario Taffurelli, Pier-Luigi Lollini, Patrizia Nanni. Patient derived xenografts of breast carcinoma of different intrinsic subtypes. Functional stability of serial passages: virtues and vices.
Presentazioni a congressi:
- A. Palladini, V. Giusti, L. Landuzzi, M.L. Ianzano, A. Lamolinara, M. Dall’Ora, T. Balboni, R. Laranga, P. Nanni, P.L. Lollini. Loss of HER2 and gain of aggressiveness in HER2- positive mammary tumours: To go beyond anti-HER2 therapy. EACR-AACR-SIC Special Conference 2017, Firenze
- A. Palladini, M. Dall’Ora, T. Balboni, G. Nicoletti, M.L. Ianzano, R. Laranga, L. Landuzzi, V. Giusti, A. Lamolinara, A. Amici, S.M. Pupa, C. Ceccarelli, D. Santini, M. Taffurelli, E. Di Oto, M.P. Foschini, C. De Giovanni, E. Tagliabue, M. Iezzi, P. Nanni, P-L. Lollini. HER2 isoform interaction in mammary carcinoma onset and progression. AACR 2016, New Orleans (USA)
- A. Palladini, G. Nicoletti, A. Lamolinara, M. Dall’Ora, T. Balboni, M.L. Ianzano, R. Laranga, L. Landuzzi, V. Giusti, C. De Giovanni, A. Amici, S.M. Pupa, M. Iezzi, M. Taffurelli, D. Santini, C. Ceccarelli, E. Di Oto, M.P. Foschini, P. Nanni, P-L. Lollini. HER2 isoforms co-expression differently tunes mammary carcinogenesis. SIC 2016, Verona
- Arianna Palladini, Susan Thrane, Christoph M. Janitzek, Jessica Pihl, Stine B. Clemmensen, Wilhelm A. de Jongh, Thomas M. Clausen, Giordano Nicoletti, Lorena Landuzzi, Manuel L. Penichet, Tania Balboni, Marianna L. Ianzano, Veronica Giusti, Thor H. Theander, Morten A. Nielsen, Ali Salanti, Pier-Luigi Lollini, Patrizia Nanni, Adam F. Sander. A novel viruslike particle vaccine presenting HER-2 extracellular domain elicits strong immune responses against mammary carcinoma. AACR 2018 Chicago (USA)
- Lorena Landuzzi, Marianna L. Ianzano, Claudio Ceccarelli, Enrico Di Oto, Giordano Nicoletti, Veronica Giusti, Roberta Laranga, Tania Balboni, Carla De Giovanni, Massimiliano Dall'Ora, Sofia Asioli, Arianna Palladini, Donatella Santini, Maria Pia Foschini, Mario Taffurelli, Pier-Luigi Lollini, Patrizia Nanni. Functional stability, progression and evolution of targeted drug sensitivity of HER-2-positive breast cancer patient-derived xenografts. AACR 2018 Chicago (USA).
Clinical and/or Scientific interests
Ruolo di IGF2BP3 negli esosomi derivati da modelli preclinici (linee cellulari e PDX) e fluidi biologici di pazienti con sarcoma di Ewing.